News & Insights

Gide advised Inventiva, a biopharmaceutical company listed on Euronext Paris and the NASDAQ Global Market, specializing in the development of oral the...

Gide advised the arrangers and underwriters in connection with the financing of Iliad S.A.’s contemplated acquisition of certain assets of the Altice ...

Gide advised EMZ Partners in connection with the LBO of Nexteam group structured, alongside Nexteam group senior management led by Ludovic Asquini, it...

Gide advised Crédit Industriel et Commercial, HSBC Continental Europe and The Governor and Company of the Bank of Ireland on the financing implemented...

Gide has advised JACQUEMUS on the signing of a long-term exclusive beauty partnership with the L’Oréal Group, further solidified by L’Oréal’s minority...

Gide is advising Axdis and its family shareholders on the planned merger with Powr Group, which would result in a strategic merger between two major p...

Gide advised Mizuho Bank Europe N.V., Mizuho Bank, Ltd., London Branch, Natixis, NatWest Bank Europe GmbH, NatWest Markets N.V., and Société Générale,...

Gide advised Roquette Frères, a global leader of plant-based ingredients and world-class player in pharmaceutical excipients, for the health and nutri...

Gide has advised the consortium formed by Vauban Infrastructure Partners via funds it manages (Vauban), with a 50.1% stake, and Caisse des Dépôts et C...

Gide advised Limagrain, an agricultural cooperative owned by French farmers, and 4th largest seed group in the world, on the simplified tender offer o...